A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells Adam J. ShuhendlerRichard Y. CheungXiao Yu Wu Preclinical Study 17 February 2009 Pages: 255 - 269
Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells Elif Damla ArisanOzgur KutukHuveyda Basaga Preclinical Study 24 February 2009 Pages: 271 - 281
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen Hany Onsy HabashyDesmond G. PoweJulia M. W. Gee Preclinical Study 24 February 2009 Pages: 283 - 293
Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population A-Yong CaoWei JinZhi-Ming Shao Preclinical Study 24 February 2009 Pages: 295 - 303
Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density Wei Tse YangMichael T. LewisJenny C. Chang Preclinical Study 25 February 2009 Pages: 305 - 314
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer Robin L. JonesJanine SalterMitchell Dowsett Preclinical Study 27 February 2009 Pages: 315 - 323
Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin) Margarete K. AkensMichael R. HardistyAlbert J. M. Yee Preclinical Study 05 March 2009 Pages: 325 - 333
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue Dung-Tsa ChenAejaz NasirTimothy Yeatman Preclinical Study 06 March 2009 Pages: 335 - 346
Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients Amadeo M. ParissentiJudy-Anne W. ChapmanMaureen E. Trudeau Clinical trial 22 September 2009 Pages: 347 - 356
Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node Andraž PerhavecMaja Pohar PermeJanez Žgajnar Clinical trial 29 September 2009 Pages: 357 - 366
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients K. HanckeD. GrubeckJ. M. Weiss Clinical trial 16 October 2009 Pages: 367 - 377
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer Matthew J. EllisLi LinJosé Baselga Clinical Trial 21 October 2009 Pages: 379 - 390
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) Marilyn L. SlovakVictoria BedellWendy Stock Clinical trial 23 October 2009 Pages: 391 - 398
Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition Inge-Marie A. ObdeijnClaudette E. LooCarla Boetes Clinical trial 30 October 2009 Pages: 399 - 407
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2 S. M. DomchekM. M. GaudetM. Robson Clinical trial 03 November 2009 Pages: 409 - 414
The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast R. M. MannC. E. LooC. Boetes Clinical trial 03 November 2009 Pages: 415 - 422
Variation in genes required for normal mitosis and risk of breast cancer J. E. OlsonX. WangF. J. Couch Epidemiology 18 April 2009 Pages: 423 - 430
Mutations in the mitochondrial DNA D-loop region and breast cancer risk Chuanzhong YeXiao Ou ShuQiuyin Cai Epidemiology 21 April 2009 Pages: 431 - 436
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer Gabrielle ColleranNiall McInerneyElinor Sawyer Epidemiology 24 April 2009 Pages: 437 - 442
ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy Laura La PagliaAnthony LaugéDominique Stoppa-Lyonnet Epidemiology 29 April 2009 Pages: 443 - 452
Association of genetic variation in mitotic kinases with breast cancer risk Xianshu WangZachary S. FredericksenFergus J. Couch Epidemiology 30 April 2009 Pages: 453 - 462
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Epidemiology 08 May 2009 Pages: 463 - 474
Erratum to: Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Erratum 19 September 2009 Pages: 475 - 475
Green tea consumption and breast cancer risk or recurrence: a meta-analysis Adeyemi A. OgunleyeFei XueKarin B. Michels Epidemiology 13 May 2009 Pages: 477 - 484
Are mammography recommendations in women younger than 40 related to increased risk? Julie M. KappBonnie C. YankaskasMichael L. LeFevre Report 16 January 2009 Pages: 485 - 490
Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors Jeremy M. ArnoldDavid Y. H. ChoongGeorgia Chenevix-Trench Report 03 February 2009 Pages: 491 - 496
Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-β1 and TNF-α Javier GuerreroNicolás TobarJorge Martínez Letter to the editor 01 August 2009 Pages: 497 - 508
Association between polymorphisms of XRCC1 and offspring sex ratio at births in families of female breast cancer patients Mostafa SaadatIraj Saadat Letter to the editor 22 August 2009 Pages: 509 - 510
